|
Functional bioassays are critical for the development of complex biologic drugs for immunotherapy. Mechanism of action (MoA)-based bioassays are used throughout the drug development pipeline for antibody screening, characterization, potency testing and stability studies.
Through the presentation of case studies, this webinar will illustrate best practices in method development that result in reliable, reproducible and precise assays, and provide insight into which bioassays may be most suitable for your development program. Specifically, this webinar will address:
- How bioassays are being used in the life cycle of a biologic drug
- Requirements for mAb functional bioassays
- MoA-based assays for mAbs including cytokine signaling, CDC, ADCC and ADCP assays
- Use of bioassays for biocomparability studies
This presentation will be of interest to any researcher involved in bioassay development, biologics drug development, quality control and biologics manufacture.
Attendees will have an opportunity to chat live with Charles River and Promega experts during the webinar presentation.
Not able to attend the webinar?
Register anyway – All registrants will receive an email following the webinar with links to the webinar recording, a pdf of the slide presentation and additional information you may find helpful.
|
